Market Scope
Market Research Future (MRFR) projects that the Cell Culture Media Market Share could hold a value of more than USD 4,337.83 million by the end of 2027. Over the analysis period (2020 to 2027), the market will procure a CAGR of 8.33%, says MRFR.
Get Sample Report: https://www.marketresearchfuture.com/sample_request/4462
Top Growth Drivers and Challenges
The cell culture media industry is thriving on the back of the rapid expansion of the pharmaceutical industry combined with the burgeoning pharma drug pipeline. Accelerated cancer cases coupled with the rise in various infectious disorders, along with the blossoming elderly populace would further add to the market worth. The increase in research activities have led to emergence of advanced drugs as well as therapies to help address the high burden of chronic ailments. These factors are presumed to give rise several lucrative opportunities for the cell culture media players in the ensuing years.
Emerging countries such as Brazil, India, and China are a few attractive destinations for the vendors specializing in stem cell cultures. These countries enjoy relatively lenient regulatory standards with respect to stem cell-based tests as well as a favorable business scenario. The launch of novel 3d cell culture methods and the mounting of these methods for vaccine and biopharmaceutical production will also enhance the market share. Various firms are entering acquisitions and mergers to enhance their product ranges, which is yet another factor that would foster the market growth in the years ahead.
Renowned Market Firms
The affluent contenders active in the cell culture industry include The Sartorius Group (Germany), GE Healthcare (US), Fujifilm Holdings Corporation (Japan), Thermo Fisher Scientific Inc. (US), Corning Incorporated (US), Becton, Dickinson and Company (US), Lonza (Switzerland), Bio-Rad Laboratories, Inc. (US), HiMedia Laboratories (India), Merck KGaA (Germany), PromoCell (Germany), Sera Scandia A/S (Denmark), and many more.
Market Segmentation
The major segments studied in the evaluation report include product type, application, as well as end user.
Top product types listed in the MRFR analysis include media, sera as well as reagents.
A few key applications of the cell culture media profiled in the report are gene therapy, biopharmaceutical, cytogenetic, tissue-culture and manufacturing, and others.
Primary end-users of cell culture media include biopharmaceutical companies, academic and research laboratories, hospitals and diagnostics centers, and many more.
The cell culture market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. The presence of major market players, such as Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, etc., is increasing the overall competitive rivalry of the market. These companies generally focus on marketing strategies including acquisitions, mergers, agreements, and partnerships for a better position. A case in point, in January 2022, Thermo Fisher Scientific Inc. acquired PeproTech for a total of close to USD 1.85 billion. Headquartered in New Jersey, US, PeproTech is a privately owned developer of bioscience reagents called recombinant proteins, such as cytokines as well as growth factors. These recombinant proteins play an important role in various cell culture applications, particularly in cellular research models. PeproTech's range of recombinant proteins is expected to complement Thermo Fisher's advanced cell culture media products.
Regional Outlook
The American market is currently prevailing as the top performer and would continue to retain its lead throughout the conjectured period. High spending on R&D activities by major pharmaceutical and biotech vendors, rising burden of chronic disorders and the resultant surge in the requirement for advanced drugs and vaccines also benefit the American market.
APAC could be the fastest progressing market for cell culture media in the following years, thanks to the escalating number of research institutes and the availability of lower-priced labor and manufacturing costs. Rapid upgradation of the healthcare infrastructure and American and European vendors making heavy investments in China and India will also work in favor of the regional industry.
Access Report Details @ https://www.marketresearchfuture.com/reports/cell-culture-media-market-4462
Related Report: Global Cardiopulmonary Resuscitation Market Research Report—Forecast till 2027
Global Urinary Tract Infection Market Research Report—Forecast till 2027
Impact of COVID-19 Outbreak on Healthcare Market
FFP2 Grade Protective Masks Market Research Report—Forecast till 2027
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
